🇺🇸 FDA
Pipeline program

Carboplatin

ACNS1123

Phase 2 small_molecule completed

Quick answer

Carboplatin for Central Nervous System Nongerminomatous Germ Cell Tumor is a Phase 2 program (small_molecule) at Children's Hospital of Fudan University with 1 ClinicalTrials.gov record(s).

Program details

Company
Children's Hospital of Fudan University
Indication
Central Nervous System Nongerminomatous Germ Cell Tumor
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials